Can allergic inflammation cause Eustachian tube swelling and ear symptoms?

Mechanistic pathways

• Allergic cascade: Inhaled allergens trigger an IgE-mediated Th2 immune response and mast cell activation at the nasopharyngeal Eustachian tube (ET) orifice. The resulting release of histamine, leukotrienes, and cytokines (IL-4 and IL-5) drives vasodilation, venous engorgement, and increased vascular permeability, causing acute mucosal edema and tissue thickening.
• Mucus hypersecretion: This inflammatory signaling simultaneously induces goblet-cell hyperplasia and the overexpression of highly viscous mucins (specifically MUC5AC and MUC5B). The combination of mucosal swelling and thick mucus accumulation physically narrows and obstructs the ET lumen.

Pathophysiological consequences

• Ventilation failure and pressure: The mechanical narrowing and functional obstruction of the ET impair its opening mechanisms, preventing effective middle-ear ventilation. As trapped air is absorbed by the surrounding mucosa, it generates localized negative pressure that clinically manifests as ear pressure and aural fullness.
• Fluid accumulation: Chronic negative pressure induces fluid transudation (effusion) within the middle ear cleft. Because the mastoid air cells are contiguous with the middle ear cavity, this effusion routinely extends into the mastoid system, resulting in mastoid fluid.
• Hearing symptoms and tinnitus: The fluid collection and pressure dysregulation stiffen the tympanic membrane and ossicular chain while adding mass, restricting sound transmission and causing conductive hearing loss. This loss of ambient external sound, combined with altered middle-ear mechanics, makes internal auditory perceptions more prominent, contributing to secondary tinnitus.

Bottom line

• Allergic inflammation directly initiates a cascade of mucosal swelling and viscous mucus hypersecretion that obstructs the Eustachian tube. This ventilation failure generates negative pressure and fluid effusion extending to the mastoid cells, ultimately driving the clinical presentation of ear pressure, conductive hearing loss, and secondary tinnitus.